Sanofi committed to India despite 'perverse', 'shocking' and 'arbitary' Indian tax plans
This article was originally published in Scrip
Executive Summary
India's plans to retrospectively allow capital gains tax on cross-border acquisitions has drawn widespread disparagement, with experts saying that such significant changes in legislation could dramatically alter returns for companies and erode the country's attractiveness as a destination for foreign investments.